StockData
NovoCure Ltd logo

NovoCure Ltd (NVCR) stock

NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3027% below fair value
$11.83+0.11 (+0.94%)

Close on Nov 13, 2026Market cap $1.38BP/E –Yield –

NovoCure profit margin

Profit margin (net margin) is net income as a percentage of revenue.

NovoCure's profit margin for the twelve months ending Sep 30, 2026 was -16.8%. For fiscal 2025 it was -20.8%, against -27.9% the year before. The highest annual figure on record is 4.0% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-20.8%+7.1
FY2024Dec 31, 2024-27.9%+12.8
FY2023Dec 31, 2023-40.6%−23.4
FY2022Dec 31, 2022-17.2%−6.3
FY2021Dec 31, 2021-10.9%−14.9
FY2020Dec 31, 20204.0%+6.1
FY2019Dec 31, 2019-2.1%+23.6
FY2018Dec 31, 2018-25.6%+9.2
FY2017Dec 31, 2017-34.8%+124.2
FY2016Dec 31, 2016-159.1%+178.2
FY2015Dec 31, 2015-337.2%+183.6
FY2014Dec 31, 2014-520.9%+226.0
FY2013Dec 31, 2013-746.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-5.4%+16.9
Q2 FY2026Jun 30, 2026-8.5%+16.7
Q1 FY2026Mar 31, 2026-40.9%−18.7
Q4 FY2025Dec 31, 2025-14.1%+26.8
Q3 FY2025Sep 30, 2025-22.3%−2.6
Q2 FY2025Jun 30, 2025-25.3%−3.1
Q1 FY2025Mar 31, 2025-22.1%+5.8
Q4 FY2024Dec 31, 2024-40.9%−5.7
Q3 FY2024Sep 30, 2024-19.7%+19.2
Q2 FY2024Jun 30, 2024-22.2%+23.4
Q1 FY2024Mar 31, 2024-28.0%+15.4
Q4 FY2023Dec 31, 2023-35.2%−6.1
Q3 FY2023Sep 30, 2023-38.9%−18.6
Q2 FY2023Jun 30, 2023-45.6%−28.5
Q1 FY2023Mar 31, 2023-43.4%−40.0
Q4 FY2022Dec 31, 2022-29.0%−9.2
Q3 FY2022Sep 30, 2022-20.3%−10.5
Q2 FY2022Jun 30, 2022-17.0%−6.1
Q1 FY2022Mar 31, 2022-3.4%−0.3
Q4 FY2021Dec 31, 2021-19.9%−23.3
Q3 FY2021Sep 30, 2021-9.8%−16.8
Q2 FY2021Jun 30, 2021-11.0%−12.4
Q1 FY2021Mar 31, 2021-3.1%−6.9
Q4 FY2020Dec 31, 20203.4%−0.9
Q3 FY2020Sep 30, 20207.0%+4.9
Q2 FY2020Jun 30, 20201.4%+2.9
Q1 FY2020Mar 31, 20203.9%+20.5
Q4 FY2019Dec 31, 20194.3%+26.7
Q3 FY2019Sep 30, 20192.1%+20.2
Q2 FY2019Jun 30, 2019-1.5%+23.7
Q1 FY2019Mar 31, 2019-16.6%+23.2
Q4 FY2018Dec 31, 2018-22.4%−2.0
Q3 FY2018Sep 30, 2018-18.1%+4.9
Q2 FY2018Jun 30, 2018-25.2%+30.0
Q1 FY2018Mar 31, 2018-39.8%+12.0
Q4 FY2017Dec 31, 2017-20.4%+52.9
Q3 FY2017Sep 30, 2017-22.9%–
Q2 FY2017Jun 30, 2017-55.2%–
Q1 FY2017Mar 31, 2017-51.7%–
Q4 FY2016Dec 31, 2016-73.3%–

More NovoCure figures

See a number that looks wrong?